全球數位化糖尿病管理市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球數位糖尿病管理市場預計將從2025年的311.8億美元成長到2034年的1,016.2億美元，2026年至2034年的複合年成長率（CAGR）為14.03%。隨著數位健康技術的進步，全球數位糖尿病管理市場正在快速擴張。全球糖尿病患者數量的不斷成長推動了對持續監測和管理工具的需求日益成長。行動應用程式、穿戴式裝置和連網血糖值正在幫助提高患者參與度和治療效果。

智慧型手機和穿戴式健康設備的普及是成長要素。遠端醫療服務和遠端患者監護系統日益普及，尤其是在疫情期間。人們對自我護理和預防醫學意識的提高也促進了市場成長。此外，醫療服務提供者也正在採用數位化平台，以便更有效地追蹤病患資料。

未來，在人工智慧 (AI) 和數據分析技術進步的推動下，市場預計將迎來強勁成長。數位化工具與醫療保健系統的整合將進一步提升個人化治療方案的發展。然而，資料隱私問題和設備高成本可能會在某些地區阻礙技術的普及。總體而言，醫療保健產業的數位轉型將為長期成長提供支援。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球數位化糖尿病管理市場：依產品與服務分類

• 市場分析、洞察與預測
• 設備（智慧血糖儀、持續血糖監測（CGM）系統、智慧胰島素筆、智慧胰島素幫浦/閉合迴路幫浦和智慧胰島素貼片）
• 按用途分類的應用程式（糖尿病/血糖值追蹤應用程式、肥胖/飲食管理應用程式）
• 資料管理軟體和平台
• 服務

第5章 全球數位糖尿病管理市場：依設備類型分類

• 市場分析、洞察與預測
• 攜帶式
• 穿戴式裝置

第6章 全球數位糖尿病管理市場：依最終用戶分類

• 市場分析、洞察與預測
• 自我照顧/居家醫療
• 醫院和糖尿病診所
• 學術研究機構

第7章 全球數位糖尿病管理市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Dexcom
  • Medtronic
  • Insulet
  • Roche
  • Novo Nordisk
  • Tandem Diabetes Care
  • Omada Health
  • DarioHealth
  • Ascensia Diabetes Care
  • MySugr/Roche
  • Senseonics
  • Embecta
  • EOFlow
  • Sequel Med Tech
  • Beta Bionics
  • Bigfoot Biomedical
  • AgaMatrix
  • Livongo/Teladoc
  • Glooko

The global digital diabetes management market size is expected to reach USD 101.62 Billion in 2034 from USD 31.18 Billion in 2025, growing at a CAGR of 14.03% during 2026-2034.The global digital diabetes management market has expanded rapidly with the growth of digital health technologies. Rising diabetes cases worldwide have increased the need for continuous monitoring and management tools. Mobile apps, wearable devices, and connected glucose monitors have improved patient engagement and treatment outcomes.

Major drivers include the increasing use of smartphones and wearable health devices. Telemedicine services and remote patient monitoring systems have gained popularity, especially after the pandemic. Growing awareness about self-care and preventive healthcare supports market growth. Healthcare providers are also adopting digital platforms to track patient data more effectively.

Looking ahead, the market is expected to grow strongly with advancements in artificial intelligence and data analytics. Integration of digital tools with healthcare systems will improve personalized treatment plans. However, data privacy concerns and high device costs may limit adoption in some regions. Overall, digital transformation in healthcare will support long-term growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches)
• Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps)
• Data Management Software & Platforms
• Services

By Device Type

• Handheld Devices
• Wearable Devices

By End User

• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes

COMPANIES PROFILED

• Abbott, Dexcom, Medtronic, Insulet, Roche, Novo Nordisk, Tandem Diabetes Care, Omada Health, DarioHealth, Ascensia Diabetes Care, mySugr/Roche, Senseonics, embecta, EOFlow, Sequel Med Tech, Beta Bionics, Bigfoot Biomedical, AgaMatrix, Livongo/Teladoc, Glooko

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Data Management Software & Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device Type
• 5.2. Handheld Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Self/Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Specialty Diabetes Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Service
  • 7.2.2 By Device Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Service
  • 7.3.2 By Device Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Service
  • 7.4.2 By Device Type
  • 7.4.3 By End User
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Service
  • 7.5.2 By Device Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Service
  • 7.6.2 By Device Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIGITAL DIABETES MANAGEMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Dexcom
  • 9.2.3 Medtronic
  • 9.2.4 Insulet
  • 9.2.5 Roche
  • 9.2.6 Novo Nordisk
  • 9.2.7 Tandem Diabetes Care
  • 9.2.8 Omada Health
  • 9.2.9 DarioHealth
  • 9.2.10 Ascensia Diabetes Care
  • 9.2.11 MySugr/Roche
  • 9.2.12 Senseonics
  • 9.2.13 Embecta
  • 9.2.14 EOFlow
  • 9.2.15 Sequel Med Tech
  • 9.2.16 Beta Bionics
  • 9.2.17 Bigfoot Biomedical
  • 9.2.18 AgaMatrix
  • 9.2.19 Livongo/Teladoc
  • 9.2.20 Glooko